September 10, 2025Siberian Journal of OncologyOpen Access

Treatment outcomes in colorectal cancer patients with synchronous liver metastases

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Pilot study reports 2-year survival rates in colorectal cancer patients with synchronous liver metastases, suggesting chemotherapy effectiveness.

The 2-year recurrence-free survival rate reached 76.7%, highlighting effective treatment outcomes.
Patients with ypN0 lymph node status had a 100% survival rate, indicating the importance of lymph node involvement.
Overall survival for patients showed a striking 96.7%, demonstrating the benefits of combined modality treatment.
Synchronous liver metastases led to a survival decrease from 94.1% with 1-3 lesions to 50% with 7-11 lesions.

Dobrodeev et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Pilot study reports 2-year survival rates in colorectal cancer patients with synchronous liver metastases, suggesting chemotherapy effectiveness.